Evommune, Inc. · NYSE:EVMN
Ra Capital Management, L.P. reported a 11.00% stake in Evommune, Inc. (Schedule 13D)
Event Nov 7, 2025 · Filed Nov 17, 2025
Ra Capital Management, L.P. reported a 11.00% stake in Evommune, Inc., 3,458,770 shares, with active intent on Nov 7, 2025. Filed Nov 17, 2025 (Schedule 13D).
- Stake
- 11.00%
- Shares
- 3,458,770
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 11.00% | 3,458,770 |
| Peter Kolchinsky | 11.00% | 3,458,770 |
| Rajeev Shah | 11.00% | 3,458,770 |
| RA Capital Healthcare Fund, L.P. | 8.50% | 2,674,425 |
Source
Related
- Evommune, Inc.
- Ra Capital Management, L.P.
- Evommune, Inc. shareholders
- Schedule 13D/A · Ra Capital Management, L.P. · Feb 17, 2026
- Form 4 · Pena Luis C. · Oct 15, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Andera Partners · Aug 14, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Jul 16, 2026
- Form 4 · Carver Kyle · Jul 10, 2026